FRED ITVELDT: Open Payments
NPI 1619393204 · SPOKANE VALLEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 13 payments from 7 companies in 2025. Trend: 2023 $284 · 2024 $1,012 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $351 |
| Axsome Therapeutics, Inc. | 2 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: INVEGA SUSTENNA, SPRAVATO, Auvelity, REXULTI, AUSTEDO XR, INGREZZA, COBENFY.
Industry payments across WA — which companies pay providers there.
